- Home
- Publications
- Publication Search
- Publication Details
Title
Gene and virotherapy for hematological malignancies
Authors
Keywords
Gene therapy, Virotherapy, Immunovirotherapy, Purging, Clinical trials
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 104, Issue 1, Pages 29-41
Publisher
Springer Nature
Online
2016-06-11
DOI
10.1007/s12185-016-2031-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 513. Armed-Ad Gene Therapy Expressing PD-L1 Minibody Enhances the Anti-Tumor Effect of Adoptively Transferred Chimeric Antigen Receptor T-Cells for Solid Tumor Treatment
- (2016) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- 515. Oncolytic Adenovirus Armed with Cytokines Enhances CAR-T Cell Efficacy in Pancreatic Tumor Model
- (2016) Keisuke Watanabe et al. MOLECULAR THERAPY
- Transcriptional gene silencing in humans
- (2016) Marc S. Weinberg et al. NUCLEIC ACIDS RESEARCH
- Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+T-cell axis
- (2016) Craig M. Brackett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
- (2015) Shiri Weinstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Measles Edmonston vaccine strain derivatives have potent oncolytic activity against osteosarcoma
- (2014) E Domingo-Musibay et al. CANCER GENE THERAPY
- Paradoxical Decrease in the Capture and Lymph Node Delivery of Cancer Vaccine Antigen Induced by a TLR4 Agonist as Visualized by Dual-Mode Imaging
- (2014) D. K. Kadayakkara et al. CANCER RESEARCH
- RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes
- (2014) Katrin K Fleischmann et al. Molecular Cancer
- Reovirus as a successful ex vivo purging modality for multiple myeloma
- (2013) C M Thirukkumaran et al. BONE MARROW TRANSPLANTATION
- Leukemia Cell-Rhabdovirus Vaccine: Personalized Immunotherapy for Acute Lymphoblastic Leukemia
- (2013) D. P. Conrad et al. CLINICAL CANCER RESEARCH
- Oncolytic measles virus strains as novel anticancer agents
- (2013) Pavlos Msaouel et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Oncolytic myxoma virus: The path to clinic
- (2013) Winnie M. Chan et al. VACCINE
- Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
- (2013) C Batenchuk et al. Blood Cancer Journal
- Selective Purging of Human Multiple Myeloma Cells from Autologous Stem Cell Transplantation Grafts using Oncolytic Myxoma Virus
- (2012) Eric Bartee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Sindbis viral vectors target hematopoietic malignant cells
- (2012) R Suzme et al. CANCER GENE THERAPY
- Infectivity-selective Oncolytic Adenovirus Developed by High-throughput Screening of Adenovirus-formatted Library
- (2012) Yoshiaki Miura et al. MOLECULAR THERAPY
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
- (2011) X. Wang et al. BLOOD
- Considerations for the Clinical Application of Chimeric Antigen Receptor T Cells: Observations from a Recombinant DNA Advisory Committee Symposium Held June 15, 2010
- (2011) H. C. J. Ertl et al. CANCER RESEARCH
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo depletion of T lymphocyte-specific transcription factors by RNA interference
- (2010) Antoine Tesniere et al. CELL CYCLE
- K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate
- (2010) B. D. Smith et al. CLINICAL CANCER RESEARCH
- Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus
- (2010) Masmudur M. Rahman et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Use of attenuated paramyxoviruses for cancer therapy
- (2010) Patrycja J Lech et al. Expert Review of Vaccines
- Suicide gene therapy for graft-versus-host disease
- (2010) Anna-Maria Georgoudaki et al. Immunotherapy
- A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation
- (2009) X. Zheng et al. BLOOD
- Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study
- (2009) Fabio Ciceri et al. LANCET ONCOLOGY
- Myxoma virus targets primary human leukemic stem and progenitor cells while sparing normal hematopoietic stem and progenitor cells
- (2009) M Kim et al. LEUKEMIA
- Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus
- (2009) Tuba Esfandyari et al. Molecular Oncology
- Impaired interferon signaling is a common immune defect in human cancer
- (2009) R. J. Critchley-Thorne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone
- (2008) Yasushi Sato et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now